Literature DB >> 21252519

Experimental models of lupus nephritis.

Joseph P Grande1.   

Abstract

A number of murine models recapitulate many of the features of systemic lupus. Spontaneous models of lupus have provided the basis for genetic linkage studies to define loci that confer an increased risk of nephritis in susceptible mice. Functional relevance of genes within susceptibility loci have been verified through the use of transgenic mice bearing targeted deletions or overexpression of candidate genes. Critical gene targets are involved in the production of autoantigens, stimulation of B cells to produce autoantibodies, stimulation of T cells to provide B cell help and cytokine-mediated damage following tissue deposition of immune complexes. In this overview, features of the commonly employed models of human lupus nephritis are reviewed. Strategies to identify candidate genes involved in the initiation and progression of lupus nephritis in these models are discussed. Finally, key studies to validate target genes as pathophysiologically relevant mediators of lupus nephritis and studies to identify potential targets for therapeutic intervention are summarized.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252519     DOI: 10.1159/000319241

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  11 in total

1.  Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.

Authors:  Celine C Berthier; Ramalingam Bethunaickan; Tania Gonzalez-Rivera; Viji Nair; Meera Ramanujam; Weijia Zhang; Erwin P Bottinger; Stephan Segerer; Maja Lindenmeyer; Clemens D Cohen; Anne Davidson; Matthias Kretzler
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

2.  Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.

Authors:  Zeming Zhang; Dongmei Liu; Xiaoli Zhang; Xiaofei Wang
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

3.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

4.  Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study.

Authors:  Lixiu Li; Yuncheng Xia; Chunmei Chen; Ping Cheng; Canhui Peng
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.

Authors:  Celine C Berthier; Matthias Kretzler; Anne Davidson
Journal:  J Data Mining Genomics Proteomics       Date:  2012-03-27

6.  The relationship between neutrophil-lymphocyte ratio and early renal fibrosis and renal prognosis in patients with lupus nephritis.

Authors:  Guming Zou; Hongmei Gao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

7.  1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.

Authors:  Xuewei Li; Jie Liu; Yingzhe Zhao; Ning Xu; E Lv; Chunzeng Ci; Xiangling Li
Journal:  BMC Nephrol       Date:  2022-07-08       Impact factor: 2.585

Review 8.  Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Clin Dev Immunol       Date:  2012-06-14

9.  Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.

Authors:  Tao Jiang; Fei Tian; Hongting Zheng; Samantha A Whitman; Yifeng Lin; Zhigang Zhang; Nong Zhang; Donna D Zhang
Journal:  Kidney Int       Date:  2013-09-11       Impact factor: 10.612

10.  The Pathogenesis of Lupus Nephritis.

Authors:  Rosalie M Sterner; Stella P Hartono; Joseph P Grande
Journal:  J Clin Cell Immunol       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.